Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
0.6688
+0.0109 (1.66%)
At close: Dec 31, 2025, 4:00 PM EST
0.6401
-0.0287 (-4.29%)
After-hours: Dec 31, 2025, 6:32 PM EST
Harvard Bioscience Analyst Ratings
Total Analysts
3
Consensus Rating
Buy
Price Target
$2.50
Upside
+273.80%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Buy Maintains $3 → $2 | Buy | Maintains | $3 → $2 | +199.04% | Sep 10, 2025 |
| Benchmark | Benchmark | Buy Maintains $4.5 → $3 | Buy | Maintains | $4.5 → $3 | +348.56% | May 13, 2025 |
| Keybanc | Keybanc | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Apr 9, 2025 |
| Benchmark | Benchmark | Buy Maintains $5.5 → $4.5 | Buy | Maintains | $5.5 → $4.5 | +572.85% | Mar 24, 2025 |
| Benchmark | Benchmark | Buy Reiterates $7 | Buy | Reiterates | $7 | +946.65% | Jun 22, 2023 |
| Benchmark | Benchmark | Strong Buy Maintains $4 → $7 | Strong Buy | Maintains | $4 → $7 | +946.65% | Apr 26, 2023 |
| Keybanc | Keybanc | Buy Maintains $5 → $7 | Buy | Maintains | $5 → $7 | +946.65% | Apr 26, 2023 |
| Benchmark | Benchmark | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +498.09% | Mar 10, 2023 |
| Keybanc | Keybanc | Buy Maintains $7 → $5 | Buy | Maintains | $7 → $5 | +647.61% | Nov 9, 2022 |
| Keybanc | Keybanc | Buy Maintains $10 → $7 | Buy | Maintains | $10 → $7 | +946.65% | Aug 5, 2022 |
| Keybanc | Keybanc | Buy Initiates $6 | Buy | Initiates | $6 | +797.13% | Nov 10, 2020 |
| Benchmark | Benchmark | Buy Maintains $3.5 → $4 | Buy | Maintains | $3.5 → $4 | +498.09% | Feb 27, 2020 |
| Benchmark | Benchmark | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +1,096.17% | Jul 28, 2015 |